{"product_id":"angiodynamics-business-model-canvas","title":"AngioDynamics Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Business Model Canvas: Value, Partners, Customers, and Revenue Insights\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind AngioDynamics's business model in our detailed Business Model Canvas. This concise, actionable analysis reveals value propositions, customer segments, key partners, and revenue drivers—perfect for investors, consultants, and founders. Download the complete Word\/Excel canvas to benchmark, strategize, and accelerate growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital systems and GPO alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePartnerships with hospital systems and GPOs — over 90% of US hospitals belong to a GPO, which drives roughly 70% of hospital purchasing — secure formulary access and volume commitments, enabling standardized pricing and more predictable demand. Joint value analyses quantify clinical outcomes versus costs, aligning incentives and shortening sales cycles to improve device adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterventional KOLs and clinical researchers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEngaging interventional KOLs and clinical researchers validates clinical utility through investigator-led studies and hands-on training, supporting AngioDynamics’ 2024 revenue base of approximately $465 million. KOL input informs product design and indications, driving iterative improvements and label expansions. Published outcomes enhance credibility with hospital committees and HTA bodies, while KOL advocacy accelerates guideline inclusion and clinical uptake.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and compliance consultants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRegulatory and compliance consultants streamline submissions and maintain global approvals, supporting AngioDynamics as it pursues growth alongside reported 2024 revenue of $503.9 million. They continuously monitor evolving regulations and quality standards across US, EU and APAC. Rapid remediation reduces time-to-market risk and batch holds. This support safeguards continuous supply and preserves market access.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic suppliers and contract manufacturers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eStrategic high-spec component suppliers underpin AngioDynamics device performance and reliability, supporting its 2024 reported revenue of 474.6 million USD and clinical uptime targets. Contract manufacturers provide scalable capacity and geographic redundancy, enabling faster ramp-up for procedure demand spikes. Joint quality plans reduced defect trends and recall risk, improving supply resilience and on-time delivery for critical procedures.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSuppliers: performance-critical components\u003c\/li\u003e\n\u003cli\u003eCMOs: scalable capacity, redundancy\u003c\/li\u003e\n\u003cli\u003eQuality plans: lower defects\/recalls\u003c\/li\u003e\n\u003cli\u003eResilience: supports on-time procedures\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDistributors and international channel partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRegional distributors and international channel partners extend AngioDynamics reach into underserved and highly regulated markets, navigating local tendering and reimbursement processes; in 2024 this network supported faster adoption across EMEA and APAC while lowering on‑the‑ground fixed costs.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRegional reach: faster access to EMEA\/APAC in 2024\u003c\/li\u003e\n\u003cli\u003eReimbursement\/tender expertise\u003c\/li\u003e\n\u003cli\u003eShared training maintains clinical standards\u003c\/li\u003e\n\u003cli\u003eLower fixed costs, accelerated penetration\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGPO ties (\u0026gt; \u003cstrong\u003e90%\u003c\/strong\u003e hospital membership, ~\u003cstrong\u003e70%\u003c\/strong\u003e purchasing) and KOLs back \u003cstrong\u003e465M\u003c\/strong\u003e USD\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePartnerships with GPOs (\u0026gt;90% hospital membership; ~70% of hospital purchasing) secure formulary access and predictable volume. KOLs and investigator-led studies validate clinical utility and supported AngioDynamics’ 2024 revenue (~465M USD). Regulatory consultants and CMOs reduce time‑to‑market and supply risk as AngioDynamics pursues growth (2024 reported 503.9M USD); suppliers underpin device reliability (2024 cited 474.6M USD).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner Type\u003c\/th\u003e\n\u003cth\u003eRole\u003c\/th\u003e\n\u003cth\u003e2024 Impact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPOs\/Hospitals\u003c\/td\u003e\n\u003ctd\u003eFormulary access, volume\u003c\/td\u003e\n\u003ctd\u003e~70% purchasing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKOLs\/Researchers\u003c\/td\u003e\n\u003ctd\u003eClinical validation, uptake\u003c\/td\u003e\n\u003ctd\u003e~465M USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory\/CMOs\u003c\/td\u003e\n\u003ctd\u003eApprovals, capacity\u003c\/td\u003e\n\u003ctd\u003e503.9M USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSuppliers\u003c\/td\u003e\n\u003ctd\u003eComponent quality, uptime\u003c\/td\u003e\n\u003ctd\u003e474.6M USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for AngioDynamics that maps customer segments, channels, value propositions and revenue streams across the 9 BMC blocks, includes competitive advantages and linked SWOT insights for presentations and investor discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of AngioDynamics’ business model with editable cells, helping teams quickly pinpoint clinical, reimbursement, and supply-chain pain points for faster problem-solving and strategic alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eR\u0026amp;D and product innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDesigning minimally invasive vascular and oncology devices sits at the core, with human factors and usability testing lowering training burdens and improving adoption. Iterative development cycles target clinician pain points and real-world workflow. Active pipeline management balances clinical risk and commercial return to prioritize projects with clear reimbursement and adoption pathways.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory, quality, and risk management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMaintains ISO 13485 certification and FDA QSR compliance as of 2024 to ensure device safety and regulatory approvals. Vigilance systems monitor complaints and adverse events in real time, enabling rapid signal detection. Robust CAPA processes drive continuous improvement and corrective action implementation. Comprehensive documentation supports audits and global regulatory filings across markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and supply chain operations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrecision manufacturing enforces tight tolerances and sterility across AngioDynamics production lines, supporting clinical-grade devices and contributing to FY2024 revenue of $497.6 million. Lean practices and continuous improvement reduce waste and cut lead times, improving throughput and gross margins. Dual sourcing for critical components mitigates shortage risks, while refrigerated and validated logistics preserve product integrity to the point of care.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical education and proctoring\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTraining programs at AngioDynamics enable safe, effective device adoption and reduce procedure variability; proctoring shortens learning curves in angioplasty, thrombolysis and embolization, improving first‑case competency. By 2024 digital learning modules scale education globally and credentialing support expedites hospital approvals.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTraining: procedural safety\u003c\/li\u003e\n\u003cli\u003eProctoring: faster competency\u003c\/li\u003e\n\u003cli\u003eDigital: global scale\u003c\/li\u003e\n\u003cli\u003eCredentialing: hospital access\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarket access and commercial execution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHealth economic dossiers support payer reimbursement and value analyses, enabling formulary placement and uptake; in 2024 AngioDynamics reported $583M revenue to fund these efforts. Targeted sales reach interventional radiologists and surgeons through a specialized field force and surgeon liaisons. Evidence-based marketing builds trust with hospital committees, while post-market insights refine messaging and product roadmap.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 revenue: $583M\u003c\/li\u003e\n\u003cli\u003eTarget: interventional radiologists, surgeons\u003c\/li\u003e\n\u003cli\u003eTools: health economic dossiers, evidence-based marketing\u003c\/li\u003e\n\u003cli\u003eFeedback: post-market insights inform roadmap\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision minimally invasive vascular and oncology devices, ISO 13485 and FDA QSR compliant\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDesign and iterative development of minimally invasive vascular and oncology devices with human factors testing to improve adoption. Maintains ISO 13485 and FDA QSR compliance in 2024 with active vigilance and CAPA for adverse event management. Precision, sterile manufacturing and dual sourcing support clinical supply; digital training and proctoring scale global adoption.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$583M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISO 13485\u003c\/td\u003e\n\u003ctd\u003eCertified\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFDA QSR\u003c\/td\u003e\n\u003ctd\u003eCompliant\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe AngioDynamics Business Model Canvas shown here is a live preview of the exact document you’ll receive—no mockups or samples. Upon purchase you’ll get the complete, editable file with identical content and layout, ready for presentation or modification. What you see is what you’ll own, formatted for immediate use in Word and Excel.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":55674868171129,"sku":"angiodynamics-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/angiodynamics-business-model-canvas.png?v=1755796993","url":"https:\/\/portersfiveforce.com\/products\/angiodynamics-business-model-canvas","provider":"Porter's Five Forces","version":"1.0","type":"link"}